$6.85 Billion is the total value of Perceptive Advisors's 126 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 48.8% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| MRTX | Buy | MIRATI THERAPEUTICS INC | $570,477,000 | +80.3% | 3,435,575 | +24.0% | 8.33% | +62.5% |
| RETROPHIN INCnote 2.500% 9/1 | $390,119,000 | +11.5% | 45,000,000 | 0.0% | 5.70% | +0.4% | ||
| FOLD | Sell | AMICUS THERAPEUTICS INC | $354,723,000 | -6.6% | 25,122,048 | -0.2% | 5.18% | -15.8% |
| IOVA | Sell | IOVANCE BIOTHERAPEUTICS INC | $332,019,000 | +2.4% | 10,085,632 | -14.6% | 4.85% | -7.7% |
| GBT | Sell | GLOBAL BLOOD THERAPEUTICS IN | $319,867,000 | -13.3% | 5,800,996 | -0.7% | 4.67% | -21.9% |
| BBIO | BRIDGEBIO PHARMA INC | $251,619,000 | +15.1% | 6,706,268 | 0.0% | 3.67% | +3.6% | |
| Sell | CYTOKINETICS INCnote 4.000%11/1 | $218,301,000 | -8.4% | 9,770,000 | -2.3% | 3.19% | -17.5% | |
| ZYME | Buy | ZYMEWORKS INC | $204,999,000 | +58.7% | 4,400,999 | +22.9% | 2.99% | +43.0% |
| MYOK | MYOKARDIA INC | $190,183,000 | +41.1% | 1,395,017 | 0.0% | 2.78% | +27.2% | |
| SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $165,946,000 | +12.4% | 3,481,148 | -0.9% | 2.42% | +1.3% |
| COLLEGIUM PHARMACEUTICAL INCnote 2.625% 2/1 | $163,765,000 | +4.2% | 17,500,000 | 0.0% | 2.39% | -6.2% | ||
| ATNX | Buy | ATHENEX INC | $161,323,000 | +3.5% | 13,532,467 | +17.3% | 2.36% | -6.8% |
| VBIV | VBI VACCINES INC | $157,421,000 | -7.7% | 55,042,465 | 0.0% | 2.30% | -16.9% | |
| NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $148,924,000 | -43.0% | 1,548,715 | -27.7% | 2.17% | -48.6% |
| OM | New | OUTSET MED INC | $142,391,000 | – | 2,847,822 | +100.0% | 2.08% | – |
| NEVRO CORPnote 2.750% 4/0 | $141,822,000 | +16.7% | 9,000,000 | 0.0% | 2.07% | +5.2% | ||
| NVRO | Sell | NEVRO CORP | $115,085,000 | +7.0% | 826,164 | -8.2% | 1.68% | -3.6% |
| CRSP | New | CRISPR THERAPEUTICS AGnamen akt | $112,187,000 | – | 1,341,308 | +100.0% | 1.64% | – |
| RLAY | New | RELAY THERAPEUTICS INC | $99,209,000 | – | 2,329,407 | +100.0% | 1.45% | – |
| MGTX | MEIRAGTX HLDGS PLC | $85,176,000 | +5.8% | 6,433,277 | 0.0% | 1.24% | -4.7% | |
| QTNT | Buy | QUOTIENT LTD | $83,272,000 | -15.3% | 16,200,818 | +21.9% | 1.22% | -23.7% |
| ALBO | Buy | ALBIREO PHARMA INC | $78,758,000 | +51.7% | 2,360,139 | +20.4% | 1.15% | +36.7% |
| IMMU | Buy | IMMUNOMEDICS INC | $77,559,000 | +504.3% | 912,140 | +151.9% | 1.13% | +444.2% |
| NVAX | Buy | NOVAVAX INC | $76,681,000 | +162.8% | 707,715 | +102.2% | 1.12% | +136.8% |
| CHRS | Buy | COHERUS BIOSCIENCES INC | $66,693,000 | +584.8% | 3,636,485 | +566.9% | 0.97% | +516.5% |
| FREQ | Buy | FREQUENCY THERAPEUTICS INC | $62,558,000 | -11.3% | 3,256,518 | +7.3% | 0.91% | -20.1% |
| FMTX | FORMA THERAPEUTICS HLDGS INC | $62,300,000 | +7.2% | 1,250,000 | 0.0% | 0.91% | -3.4% | |
| KOD | Sell | KODIAK SCIENCES INC | $61,757,000 | -67.5% | 1,043,021 | -70.3% | 0.90% | -70.7% |
| BPMC | Sell | BLUEPRINT MEDICINES CORP | $61,606,000 | +14.7% | 664,574 | -3.5% | 0.90% | +3.3% |
| KDMN | KADMON HLDGS INC | $61,588,000 | -23.4% | 15,711,334 | 0.0% | 0.90% | -31.1% | |
| RTRX | RETROPHIN INC | $59,812,000 | +107.2% | 3,240,112 | 0.0% | 0.87% | +86.5% | |
| NARI | Buy | INARI MED INC | $58,563,000 | +73.7% | 848,500 | +21.9% | 0.86% | +56.6% |
| ATHA | New | ATHIRA PHARMA INC | $57,499,000 | – | 3,114,805 | +100.0% | 0.84% | – |
| CRNX | CRINETICS PHARMACEUTICALS IN | $57,342,000 | -3.1% | 3,659,381 | 0.0% | 0.84% | -12.7% | |
| PRVB | Sell | PROVENTION BIO INC | $54,729,000 | -14.3% | 4,265,711 | -5.7% | 0.80% | -22.8% |
| RCKT | ROCKET PHARMACEUTICALS INC | $50,041,000 | +9.2% | 2,189,010 | 0.0% | 0.73% | -1.5% | |
| IMVT | Buy | IMMUNOVANT INC | $49,266,000 | +83.9% | 1,400,000 | +27.3% | 0.72% | +65.7% |
| AGRX | AGILE THERAPEUTICS INC | $48,397,000 | +9.4% | 15,919,925 | 0.0% | 0.71% | -1.4% | |
| ARNA | Sell | ARENA PHARMACEUTICALS INC | $46,753,000 | -32.2% | 625,129 | -42.9% | 0.68% | -38.9% |
| ALDX | Buy | ALDEYRA THERAPEUTICS INC | $46,575,000 | +262.0% | 6,285,458 | +103.7% | 0.68% | +226.9% |
| ALLO | Sell | ALLOGENE THERAPEUTICS INC | $43,132,000 | -34.8% | 1,143,790 | -25.9% | 0.63% | -41.2% |
| COLL | COLLEGIUM PHARMACEUTICAL INC | $42,849,000 | +19.0% | 2,058,068 | 0.0% | 0.63% | +7.2% | |
| PCVX | VAXCYTE INC | $41,973,000 | +56.2% | 850,000 | 0.0% | 0.61% | +40.9% | |
| NEPT | Buy | NEPTUNE WELLNESS SOLUTIONS I | $41,012,000 | -20.6% | 19,436,906 | +5.4% | 0.60% | -28.4% |
| ADPT | Buy | ADAPTIVE BIOTECHNOLOGIES COR | $40,363,000 | +73.8% | 830,000 | +72.9% | 0.59% | +56.6% |
| ADMA | ADMA BIOLOGICS INC | $39,638,000 | -18.4% | 16,584,802 | 0.0% | 0.58% | -26.4% | |
| VYNE | New | VYNE THERAPEUTICS INC | $37,975,000 | – | 22,876,410 | +100.0% | 0.55% | – |
| CMPS | New | COMPASS PATHWAYS PLCsponsored ads | $36,554,000 | – | 1,047,404 | +100.0% | 0.53% | – |
| LYRA | LYRA THERAPEUTICS INC | $36,028,000 | -1.4% | 3,222,561 | 0.0% | 0.53% | -11.1% | |
| SILK | Buy | SILK RD MED INC | $34,956,000 | +116.7% | 520,100 | +35.1% | 0.51% | +95.4% |
| RNA | AVIDITY BIOSCIENCES INC | $34,788,000 | +10.0% | 1,235,818 | 0.0% | 0.51% | -0.8% | |
| EIDX | EIDOS THERAPEUTICS INC | $34,710,000 | +15.3% | 686,922 | 0.0% | 0.51% | +3.9% | |
| ZNTL | ZENTALIS PHARMACEUTICALS INC | $34,325,000 | -25.0% | 1,050,003 | 0.0% | 0.50% | -32.5% | |
| MGNX | Buy | MACROGENICS INC | $32,525,000 | -9.6% | 1,291,181 | +0.2% | 0.48% | -18.5% |
| TPTX | TURNING POINT THERAPEUTICS I | $28,819,000 | +35.2% | 329,890 | 0.0% | 0.42% | +22.0% | |
| BIIB | New | BIOGEN INCcall | $28,368,000 | – | 100,000 | +100.0% | 0.41% | – |
| MTEM | MOLECULAR TEMPLATES INC | $27,018,000 | -20.8% | 2,474,133 | 0.0% | 0.39% | -28.8% | |
| FUSN | FUSION PHARMACEUTICALS INC | $26,877,000 | -25.2% | 2,235,983 | 0.0% | 0.39% | -32.8% | |
| IMTX | New | IMMATICS N.V | $26,525,000 | – | 2,500,000 | +100.0% | 0.39% | – |
| VRCA | VERRICA PHARMACEUTICALS INC | $26,397,000 | -29.7% | 3,410,412 | 0.0% | 0.38% | -36.7% | |
| GERN | GERON CORP | $23,423,000 | -20.2% | 13,461,538 | 0.0% | 0.34% | -28.2% | |
| STOK | STOKE THERAPEUTICS INC | $22,505,000 | +40.5% | 671,978 | 0.0% | 0.33% | +27.0% | |
| XBI | New | SPDR SER TRput | $22,286,000 | – | 200,000 | +100.0% | 0.32% | – |
| UROV | UROVANT SCIENCES LTD | $22,106,000 | -5.1% | 2,366,831 | 0.0% | 0.32% | -14.3% | |
| RACA | New | THERAPEUTICS ACQUISITION COR | $21,570,000 | – | 1,500,000 | +100.0% | 0.32% | – |
| PMVP | New | PMV PHARMACEUTICALS INC | $21,497,000 | – | 605,556 | +100.0% | 0.31% | – |
| WVE | New | WAVE LIFE SCIENCES LTD | $21,225,000 | – | 2,500,000 | +100.0% | 0.31% | – |
| CNCE | CONCERT PHARMACEUTICALS INC | $21,119,000 | -1.3% | 2,150,641 | 0.0% | 0.31% | -11.2% | |
| ISEE | IVERIC BIO INC | $19,635,000 | +10.6% | 3,481,431 | 0.0% | 0.29% | -0.3% | |
| UMRX | New | UNUM THERAPEUTICS INC | $18,615,000 | – | 7,955,000 | +100.0% | 0.27% | – |
| VRNA | New | VERONA PHARMA PLCsponsored ads | $18,027,000 | – | 2,888,889 | +100.0% | 0.26% | – |
| CTMX | CYTOMX THERAPEUTICS INC | $17,137,000 | -20.2% | 2,577,043 | 0.0% | 0.25% | -28.2% | |
| LPTX | LEAP THERAPEUTICS INC | $16,783,000 | -3.9% | 8,476,496 | 0.0% | 0.24% | -13.4% | |
| MYL | MYLAN N.V | $14,895,000 | -7.8% | 1,004,419 | 0.0% | 0.22% | -17.2% | |
| HRMY | New | HARMONY BIOSCIENCES HLDGS IN | $14,759,000 | – | 435,377 | +100.0% | 0.22% | – |
| DRNA | DICERNA PHARMACEUTICALS INC | $14,392,000 | -29.2% | 800,000 | 0.0% | 0.21% | -36.2% | |
| SLDB | SOLID BIOSCIENCES INC | $13,702,000 | -30.7% | 6,749,803 | 0.0% | 0.20% | -37.5% | |
| AMWL | New | AMERICAN WELL CORPcl a | $13,486,000 | – | 455,000 | +100.0% | 0.20% | – |
| MORF | Sell | MORPHIC HLDG INC | $13,314,000 | -24.3% | 487,000 | -25.1% | 0.19% | -31.9% |
| ESTA | Sell | ESTABLISHMENT LABS HLDGS INC | $12,575,000 | -8.5% | 678,633 | -7.8% | 0.18% | -17.5% |
| PPH | New | VANECK VECTORS ETF TRput | $12,434,000 | – | 200,000 | +100.0% | 0.18% | – |
| DBVT | Sell | DBV TECHNOLOGIES S Asponsored adr | $11,776,000 | -63.3% | 6,806,975 | -7.0% | 0.17% | -67.0% |
| ACCD | New | ACCOLADE INC | $11,394,000 | – | 293,138 | +100.0% | 0.17% | – |
| HOLX | Sell | HOLOGIC INC | $11,300,000 | -13.8% | 170,000 | -26.1% | 0.16% | -22.2% |
| HCAT | Sell | HEALTH CATALYST INC | $10,654,000 | +8.8% | 291,084 | -13.3% | 0.16% | -1.9% |
| SCPEU | SC HEALTH CORPunit 99/99/9999 | $10,600,000 | +4.8% | 1,000,000 | 0.0% | 0.16% | -5.5% | |
| TSHA | New | TAYSHA GENE THERAPIES INC | $10,538,000 | – | 470,440 | +100.0% | 0.15% | – |
| TARA | New | PROTARA THERAPEUTICS INC | $10,242,000 | – | 608,544 | +100.0% | 0.15% | – |
| PODD | Sell | INSULET CORP | $8,927,000 | -12.9% | 37,733 | -28.4% | 0.13% | -21.7% |
| ATRC | Sell | ATRICURE INC | $8,636,000 | -63.7% | 216,449 | -59.1% | 0.13% | -67.3% |
| VRAY | VIEWRAY INC | $8,581,000 | +56.2% | 2,451,748 | 0.0% | 0.12% | +40.4% | |
| TWST | Sell | TWIST BIOSCIENCE CORP | $8,566,000 | -30.7% | 112,756 | -58.7% | 0.12% | -37.5% |
| AMRS | Buy | AMYRIS INC | $8,568,000 | +32.9% | 3,333,332 | +80.7% | 0.12% | +19.0% |
| AQST | AQUESTIVE THERAPEUTICS INC | $8,496,000 | -0.1% | 1,750,000 | 0.0% | 0.12% | -10.1% | |
| TCRR | New | TCR2 THERAPEUTICS INC | $8,128,000 | – | 400,000 | +100.0% | 0.12% | – |
| DYN | New | DYNE THERAPEUTICS INC | $8,076,000 | – | 400,000 | +100.0% | 0.12% | – |
| ONEM | Buy | 1LIFE HEALTHCARE INC | $7,936,000 | -0.2% | 279,844 | +27.9% | 0.12% | -10.1% |
| RVMD | Sell | REVOLUTION MEDICINES INC | $7,803,000 | -29.4% | 224,224 | -35.9% | 0.11% | -36.3% |
| LGVWU | LONGVIEW ACQUISITION CORPunit 99/99/9999 | $7,105,000 | +0.5% | 700,000 | 0.0% | 0.10% | -9.6% | |
| PSTX | New | POSEIDA THERAPEUTICS INC | $6,987,000 | – | 787,745 | +100.0% | 0.10% | – |
| BCTG | New | BCTG ACQUISITION CORP | $5,180,000 | – | 500,000 | +100.0% | 0.08% | – |
| HSAQ | New | HEALTH SCIENCES ACQ CORP 2 | $4,950,000 | – | 450,000 | +100.0% | 0.07% | – |
| TBIO | TRANSLATE BIO INC | $4,290,000 | -24.1% | 315,237 | 0.0% | 0.06% | -31.5% | |
| VERU | VERU INC | $4,323,000 | -21.6% | 1,650,000 | 0.0% | 0.06% | -29.2% | |
| LSACU | LIFESCI ACQUISITION CORPunit 03/31/2025 | $4,080,000 | +23.6% | 300,000 | 0.0% | 0.06% | +13.2% | |
| MOTS | MOTUS GI HLDGS INC | $4,027,000 | -27.5% | 4,210,542 | 0.0% | 0.06% | -34.4% | |
| BNR | BURNING ROCK BIOTECH LTDsponsored ads | $3,762,000 | -7.2% | 150,000 | 0.0% | 0.06% | -16.7% | |
| ATEC | ALPHATEC HLDGS INC | $3,729,000 | +41.3% | 561,574 | 0.0% | 0.05% | +25.6% | |
| ADAP | ADAPTIMMUNE THERAPEUTICS PLCsponds adr | $3,192,000 | -20.3% | 400,000 | 0.0% | 0.05% | -27.7% | |
| DFHTU | New | DEERFIELD HEALTHCARE TECH ACunit 07/16/2025 | $3,189,000 | – | 300,000 | +100.0% | 0.05% | – |
| GRTX | GALERA THERAPEUTICS INC | $2,938,000 | +26.6% | 325,000 | 0.0% | 0.04% | +13.2% | |
| REGN | Sell | REGENERON PHARMACEUTICALS | $2,799,000 | -70.1% | 5,000 | -66.7% | 0.04% | -73.0% |
| TRILLIUM THERAPEUTICS INC | $1,630,000 | +75.6% | 114,674 | 0.0% | 0.02% | +60.0% | ||
| LVGO | Sell | LIVONGO HEALTH INC | $1,493,000 | +45.8% | 10,663 | -21.7% | 0.02% | +29.4% |
| RACE | FERRARI N V | $1,141,000 | +7.6% | 6,200 | 0.0% | 0.02% | 0.0% | |
| EIGR | EIGER BIOPHARMACEUTICALS INC | $1,138,000 | -15.3% | 139,890 | 0.0% | 0.02% | -22.7% | |
| TGTX | Buy | TG THERAPEUTICS INC | $907,000 | +56.4% | 33,893 | +13.9% | 0.01% | +44.4% |
| LEGN | LEGEND BIOTECH CORPsponsored ads | $772,000 | -27.4% | 25,000 | 0.0% | 0.01% | -35.3% | |
| CLDX | New | CELLDEX THERAPEUTICS INC NEW | $738,000 | – | 49,751 | +100.0% | 0.01% | – |
| SRRA | SIERRA ONCOLOGY INC | $711,000 | -11.9% | 66,655 | 0.0% | 0.01% | -23.1% | |
| AKRO | New | AKERO THERAPEUTICS INC | $675,000 | – | 21,938 | +100.0% | 0.01% | – |
| CVET | New | COVETRUS INC | $636,000 | – | 26,075 | +100.0% | 0.01% | – |
| PSNL | New | PERSONALIS INC | $591,000 | – | 27,272 | +100.0% | 0.01% | – |
| REPL | New | REPLIMUNE GROUP INC | $443,000 | – | 19,230 | +100.0% | 0.01% | – |
| BIO | Sell | BIO RAD LABS INCcl a | $252,000 | -96.4% | 489 | -96.8% | 0.00% | -96.5% |
| OTLKW | OUTLOOK THERAPEUTICS INC*w exp 02/18/202 | $54,000 | -50.0% | 420,875 | 0.0% | 0.00% | -50.0% | |
| AVDL | Exit | AVADEL PHARMACEUTICALS PLCsponsored adr | $0 | – | -8,681 | -100.0% | -0.00% | – |
| APLS | Exit | APELLIS PHARMACEUTICALS INC | $0 | – | -11,418 | -100.0% | -0.01% | – |
| VIR | Exit | VIR BIOTECHNOLOGY INC | $0 | – | -13,024 | -100.0% | -0.01% | – |
| LMNX | Exit | LUMINEX CORP DEL | $0 | – | -18,926 | -100.0% | -0.01% | – |
| CCXI | Exit | CHEMOCENTRYX INC | $0 | – | -10,252 | -100.0% | -0.01% | – |
| CUE | Exit | CUE BIOPHARMA INC | $0 | – | -26,371 | -100.0% | -0.01% | – |
| KRMD | Exit | REPRO MED SYS INC | $0 | – | -74,813 | -100.0% | -0.01% | – |
| AKBA | Exit | AKEBIA THERAPEUTICS INC | $0 | – | -52,724 | -100.0% | -0.01% | – |
| KRTX | Exit | KARUNA THERAPEUTICS INC | $0 | – | -6,944 | -100.0% | -0.01% | – |
| MNTA | Exit | MOMENTA PHARMACEUTICALS INC | $0 | – | -30,637 | -100.0% | -0.02% | – |
| DVAX | Exit | DYNAVAX TECHNOLOGIES CORP | $0 | – | -176,950 | -100.0% | -0.02% | – |
| RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -65,839 | -100.0% | -0.03% | – |
| MDT | Exit | MEDTRONIC PLC | $0 | – | -20,000 | -100.0% | -0.03% | – |
| PHR | Exit | PHREESIA INC | $0 | – | -70,000 | -100.0% | -0.03% | – |
| IMMU | Exit | IMMUNOMEDICS INCput | $0 | – | -100,000 | -100.0% | -0.06% | – |
| AXSM | Exit | AXSOME THERAPEUTICS INC | $0 | – | -50,000 | -100.0% | -0.07% | – |
| VCRA | Exit | VOCERA COMMUNICATIONS INC | $0 | – | -290,000 | -100.0% | -0.10% | – |
| Exit | DERMTECH INC | $0 | – | -487,121 | -100.0% | -0.10% | – | |
| MRNA | Exit | MODERNA INCput | $0 | – | -100,000 | -100.0% | -0.10% | – |
| NLTX | Exit | NEOLEUKIN THERAPEUTICS INC | $0 | – | -537,425 | -100.0% | -0.14% | – |
| BLU | Exit | BELLUS HEALTH INC NEW | $0 | – | -1,125,000 | -100.0% | -0.19% | – |
| ALEC | Exit | ALECTOR INC | $0 | – | -511,731 | -100.0% | -0.20% | – |
| YMAB | Exit | Y-MABS THERAPEUTICS INC | $0 | – | -355,366 | -100.0% | -0.25% | – |
| FULC | Exit | FULCRUM THERAPEUTICS INC | $0 | – | -894,118 | -100.0% | -0.26% | – |
| Exit | DENALI THERAPEUTICS INC | $0 | – | -850,000 | -100.0% | -0.33% | – | |
| MNLO | Exit | MENLO THERAPEUTICS INC | $0 | – | -22,876,410 | -100.0% | -0.64% | – |
| BDTX | Exit | BLACK DIAMOND THERAPEUTICS I | $0 | – | -1,104,656 | -100.0% | -0.71% | – |
| AGIO | Exit | AGIO PHARMACEUTICALS INC | $0 | – | -900,000 | -100.0% | -0.78% | – |
| VAPO | Exit | VAPOTHERM INC | $0 | – | -1,338,760 | -100.0% | -0.89% | – |
| ZGNX | Exit | ZOGENIX INC | $0 | – | -4,907,139 | -100.0% | -2.15% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-16
About Perceptive Advisors
Perceptive Advisors is a New York-based hedge fund that specializes in healthcare investments. The company was founded in 1999 by Joseph Edelman, who serves as the CEO and Chief Investment Officer. Since its inception, Perceptive Advisors has become one of the most successful healthcare-focused hedge funds in the world, with over $5 billion in assets under management.
The company's investment strategy is based on a deep understanding of the healthcare industry and a focus on identifying promising companies with innovative products and technologies. Perceptive Advisors invests in a wide range of healthcare sectors, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
One of the key factors behind Perceptive Advisors' success is its team of experienced professionals. In addition to Joseph Edelman, the company's leadership team includes Adam Stone, the COO, and Jeremy Goldberg, the Chief Scientific Officer. The team also includes a group of highly skilled analysts and researchers who are experts in their respective fields.
Perceptive Advisors has a strong track record of generating high returns for its investors. However, it is important to note that investing in hedge funds carries significant risks, and investors should carefully consider their investment objectives and risk tolerance before investing. As with any investment, it is important to conduct thorough research and seek the advice of a qualified financial advisor before making any investment decisions.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| NEUROCRINE BIOSCIENCES SHARES | 42 | Q3 2023 | 15.7% |
| AMICUS THERAPEUTICS SHARES | 39 | Q3 2023 | 14.0% |
| ALDEYRA THERAPEUTICS SHARES | 35 | Q3 2023 | 3.3% |
| QUOTIENT TECHNOLOGY INC | 34 | Q3 2022 | 2.7% |
| GLOBAL BLOOD THERAPEUTICS SHARES | 29 | Q3 2022 | 9.3% |
| ADMA BIOLOGICS SHARES | 29 | Q3 2023 | 1.4% |
| RETROPHIN SHARES | 28 | Q3 2020 | 5.5% |
| DBV TECHNOLOGIES SA-SPON ADR | 28 | Q3 2021 | 1.8% |
| VBI VACCINES SHARES | 27 | Q1 2023 | 2.8% |
| IOVANCE BIOTHERAPEUTICS INC | 26 | Q3 2023 | 9.1% |
View Perceptive Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| CHEMBIO DIAGNOSTICS, INC.Sold out | May 04, 2023 | 0 | 0.0% |
| VBI Vaccines Inc/BC | April 07, 2023 | 43,509,553 | 16.7% |
| Landos Biopharma, Inc. | March 30, 2023 | 14,869,915 | 47.7% |
| REATA PHARMACEUTICALS INC | March 07, 2023 | 2,083,799 | 6.5% |
| AGILE THERAPEUTICS INCSold out | February 14, 2023 | 0 | 0.0% |
| ALBIREO PHARMA, INC. | February 14, 2023 | 1,757,160 | 8.5% |
| BELLUS Health Inc. | February 14, 2023 | 8,891,027 | 7.1% |
| CinCor Pharma, Inc. | February 14, 2023 | 2,576,325 | 5.9% |
| Coherus BioSciences, Inc.Sold out | February 14, 2023 | 0 | 0.0% |
| CONCERT PHARMACEUTICALS, INC. | February 14, 2023 | 1,800,000 | 3.6% |
View Perceptive Advisors's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| SC 13D/A | 2024-04-17 |
| SC 13D/A | 2024-04-17 |
| 4 | 2024-04-15 |
| SC 13G/A | 2024-04-15 |
| SC 13G | 2024-04-15 |
| SC 13D/A | 2024-04-10 |
| 4 | 2024-04-08 |
| 4 | 2024-04-03 |
| SC 13D/A | 2024-04-03 |
| SC 13D | 2024-03-20 |
View Perceptive Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.